Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice-Reference-Cited by-同舟云学术

Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice

Published:2017-01-01 Issue:1 Volume:66 Page:83-89
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Zhou Zhenwen¹,Dong Hui¹,Huang Yanmei¹,Yao Shuwen¹,Liang Bingshao¹,Xie Yongqiang¹,Long Yan¹,Mai Jialiang¹,Gong Sitang¹

Affiliation:

1. Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, No. 318 Renminzhong Road, Yuexiu, Guangzhou,Guangdong 510120, PR China

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference41 articles.

1. A multi-epitope vaccine CTB-UE relievesHelicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model

2. Effect of posture on13C-urea breath test in partial gastrectomy patients

3. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

4. Prevalence of Primary and Secondary Antimicrobial Resistance ofHelicobacter pyloriin Korea from 2003 through 2012

5. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candidate Antigens and the Development of Helicobacter pylori Vaccines;Helicobacter;2024-07

2. Animal Models of Helicobacter pylori Infection and Vaccines: Current Status and Future Prospects;Helicobacter;2024-07

3. Genomic and vaccine preclinical studies reveal a novel mouse-adapted Helicobacter pylori model for the hpEastAsia genotype in Southeast Asia;Journal of Medical Microbiology;2024-01-18

4. The Bacterial Spore as a Mucosal Vaccine Delivery System;International Journal of Molecular Sciences;2023-06-29

5. Creating a Vaccine-like Supplement against Respiratory Infection Using Recombinant Bacillus subtilis Spores Expressing SARS-CoV-2 Spike Protein with Natural Products;Molecules;2023-06-26